VeriSee DR is an AI-assisted diagnostic software for diabetic retinopathy (DR) that identifies high-risk DR patients. The software is intended for use on color fundus images of adults (20 years of age or older) diagnosed with diabetes. The product uses AI to provide suggestions for the classification of diabetic retinopathy (Regular tracking or Referral recommended) to assist healthcare providers in diagnosing DR. In addition, the product detects four main lesions of DR, including microaneurysms, hemorrhages, soft exudates (cotton-wool spots), and hard exudates, and shows the corresponding locations It have obtained certificate in Thailand , Indonesia, Malaysia, and Philippines FDA. VeriSee DR is an effective solution that can shorten the screening process, increase the volume of screenings, improve the accuracy and consistency of the results, reduce costs, and improve patient outcomes.